Pharma-Bio Serv, Inc.
PBSV · OTC
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,986 | $10,550 | $13,775 | $13,320 |
| - Cash | $3,957,752 | $2,093 | $7,307 | $6,767 |
| + Debt | $71,362 | $113 | $154 | $194 |
| Enterprise Value | -$3,872,404 | $8,570 | $6,622 | $6,747 |
| Revenue | $1,963,083 | $2,417 | $2,471 | $2,333 |
| % Growth | 81,118.3% | -2.2% | 5.9% | – |
| Gross Profit | $574,262 | $819 | $768 | $727 |
| % Margin | 29.3% | 33.9% | 31.1% | 31.1% |
| EBITDA | -$151 | -$38 | -$41 | -$108 |
| % Margin | -0% | -1.6% | -1.7% | -4.6% |
| Net Income | -$204 | $95 | $9 | $16 |
| % Margin | -0% | 3.9% | 0.3% | 0.7% |
| EPS Diluted | -0.009 | 0.004 | 0.37 | 0.035 |
| % Growth | -311.9% | -98.9% | 972.5% | – |
| Operating Cash Flow | $236,524 | -$302 | -$429 | $78 |
| Capital Expenditures | $0 | -$4 | $0 | $3 |
| Free Cash Flow | $236,524 | -$306 | -$429 | -$79 |